ArticleJournal of breast cancer2022

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.

Jun-Hee Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.